Halozyme Therapeutics (HALO)

Common Shares
Sell: $72.13|Buy: $72.16|Change: 2.98 (-3.97%)

Cash flow

Operating cash flow
Taxation
Investing activities
Financing
Foreign exchange adjustments
Opening balance